A Reference Framework for a $9bn Family Office
There is no universally accepted set of thresholds that institutional LPs, consultants, data providers, and investment banks use to classify private equity Buyout and Growth Equity strategies by deal-level economics. Each major source maintains its own framework, anchored to one of three primary metrics — Enterprise Value (EV) at entry, EBITDA, or Revenue — with Equity Check Size and Fund Size typically used as cross-reference variables rather than primary anchors.
The clearest pattern from sophisticated LP advisors (Cambridge Associates, Hamilton Lane, StepStone, Preqin) is that they classify funds by capitalization (and size brackets shift by vintage), while practitioner banks and data providers (PitchBook, GF Data, Houlihan Lokey, Lincoln, Capstone, Harris Williams, Argos) classify deals by EV and EBITDA. Most robust LP frameworks build multi-metric rules that combine EV plus EBITDA with sector/leverage qualifiers.
For Growth Equity narrowly defined — bootstrapped, founder-owned, near-profitable, low-leverage minority/structured majority deals — the cleanest definitions come from Cambridge Associates, StepStone, and the National Venture Capital Association (NVCA), and from the GP marketing pages of TA Associates, Summit Partners, General Atlantic, Spectrum, and JMI. Data on growth equity deal-size tiers is materially thinner than for buyout, and most public datasets contaminate "growth equity" with late-stage venture (Series C/D+ pre-profit cash burn). Any segmentation a $9bn family office adopts should therefore include explicit profitability and leverage filters to keep the bucket pure.
This report assembles thresholds from 18 distinct sources, organized into side-by-side comparison tables by metric, separately for the United States and Europe, followed by a synthesis and recommendation.
| # | Source | Type | Primary Anchor | Geography | Most Recent Data |
|---|---|---|---|---|---|
| 1 | Cambridge Associates | LP consultant / benchmark provider | Fund size (4-tier matrix; size brackets reset by vintage) | US Buyout, Ex-US Buyout, US/Ex-US Growth Equity | Q4 2024 / 2025 |
| 2 | Hamilton Lane | LP consultant / data | Total Enterprise Value (TEV) for deals; fund size tier (SMID, US Mega/Large, EU Buyout) for funds | US, EU separate | 2025 Market Overview |
| 3 | StepStone Group | LP consultant / data (SPI) | Combined criteria (revenue growth, EBITDA margin, leverage, prior institutional capital) for growth; deal EV for buyout | NA, Europe | 2022 white paper, 2025 commentary |
| 4 | Preqin | Data provider / benchmark | Fund size (vintage-adjusted) | Global, US, Europe | 2017 thresholds still in use; 2025 H1 update |
| 5 | PitchBook | Data provider | Deal EV (US Middle Market = $25M–$1B); Fund size for fund classification ($100M–$5B = mid-market funds) | US, Europe (separate "Breakdown" reports) | 2025 Annual reports; Q3 2025 European PE Breakdown |
| 6 | GF Data (ACG) | Data provider | TEV bands and EBITDA bands ($10M–$500M TEV universe) | US/Canada | Q3 2025 |
| 7 | Lincoln International / Lincoln Private Market Index | Investment bank index | EBITDA (defines "middle market" as companies with <$100M EBITDA) | US | Q1 2025 |
| 8 | Houlihan Lokey MidCapMonitor | Investment bank | Deal value (PE-sponsored debt financings); covers EU mid-cap LBOs and pan-European unitranche | Europe pan-regional + US separate | Q1/Q2 2024–2025 |
| 9 | Harris Williams, William Blair, Baird, Jefferies | Investment banks | Enterprise value (sell-side ranges) | US + Europe | 2024–2025 |
| 10 | Capstone Partners | Investment bank / Middle Market M&A Valuations Index | EV bands ($10M–$1B), EBITDA multiples by size | US | 2024 / Q4 |
| 11 | Bain & Company Global PE Report | Strategy consulting research | Deal value; defines middle market for credit as revenues <$500M and loan package <$500M | Global, with US/EU split | 2025 / 2026 |
| 12 | McKinsey Global Private Markets Review | Strategy consulting research | Fund size (small/mid-cap vs large-cap) | Global | 2024–2025 |
| 13 | Pantheon, HarbourVest, Moonfare, Sagard, Allocate | Fund-of-funds / aggregators | Composite EV/EBITDA/Revenue rules; fund-size thresholds | US + Europe | 2024–2025 |
| 14 | Invest Europe (formerly EVCA) | Industry association | Mid-market segment (qualitatively defined; aligns with Argos €15M–€500M deal range) | Europe | Mid-Market Engine for Growth 2023/2024 |
| 15 | Argos Wityu / Epsilon Research (Mid-market Argos Index®) | Eurozone benchmark | EV/EBITDA on equity value €15M–€500M target population | Eurozone only | Q3 2025 |
| 16 | EU Commission (Recommendation 2003/361) | Regulatory anchor | Headcount + turnover/balance sheet | EU | In force; Small Mid-Cap (SMC) being added |
| 17 | US Small Business Administration (SBA) | Regulatory anchor | Industry-specific employee/revenue caps | US | Current |
| 18 | NVCA, Cambridge, Callan growth-equity papers; TA, Summit, GA, Spectrum, Insight, JMI | Industry / GP self-definition | Combined: revenue growth %, profitability, prior capital, leverage | US & Europe | 2017–2024 |
| Tier | PitchBook (US PE MM Report) | GF Data (TEV bands) | Capstone Partners | Hamilton Lane (deal-level) | Houlihan Lokey shorthand | KKR (private credit) | Practitioner / Uplevered synthesis |
|---|---|---|---|---|---|---|---|
| Lower MM (LMM) | Bottom of MM ≥$25M; no LMM split | $10M–$25M TEV (small) | $10M–$250M EV | n/a (HL focus $1–3B) | <$100M EV; <$10M EBITDA | Companies with <$10M–$40M EBITDA | $10M–$75M TEV |
| Core MM | $25M–$1B EV (whole MM) | $25M–$50M and $50M–$500M | $250M–$500M EV | $1B–$3B TEV (sweet spot) | $100M–$500M EV | $40M–$100M EBITDA = upper MM lending | $75M–$500M TEV |
| Upper MM (UMM) | n/a (PB groups all $25M–$1B) | Above $500M out of GF universe | $500M–$1B EV | Top of HL $1–3B band | $500M–$1B EV | $100M–$200M+ EBITDA | $500M–$1B TEV |
| Large Cap | >$1B EV | n/a | >$1B EV | $3B–$5B+ | $1B–$5B EV | $200M+ EBITDA, syndicated loans | $1B–$5B EV |
| Mega Cap | $2.5B+ in PB; "mega buyouts" $5B+ EV | n/a | n/a | $5B+ TEV | $5B+ EV | n/a | $5B+ EV (some say $10B+) |
| Tier | Argos Wityu / Epsilon | Invest Europe Mid-Market Platform | Houlihan Lokey EU MidCapMonitor | PitchBook European PE Breakdown | AXA IM Alts / FoF practitioner | Eurazeo (own GP definition) | Pantheon / informaconnect synthesis |
|---|---|---|---|---|---|---|---|
| Lower MM | €15M–€500M equity (whole MM); upper-vs-lower spread up to 5x EBITDA | Qualitative ("medium-sized") | Lower bound ~€20M EV (Spain regional) | Median European PE deal €30–50M | LMM equivalent | Elevate strategy: tickets up to €150M | <€100M EV |
| Core MM | €15M–€500M equity (entire bracket) | "Mid-Market" — qualitative; uses Cambridge benchmark | €100M–€1B EV LBOs | Mid-market = €50M–€500M | €50M–€500M EV | Capital strategy: upper midcap below €150–200M EV | €100M–€500M EV |
| Upper MM | Top of MM = €500M equity | "Upper mid-market" referenced qualitatively | €1B+ deal threshold for EU large-cap LBO | Large-cap >€500M | €500M–€1B EV | Capital upper midcap; over €200M EV | €500M–€1B EV |
| Large Cap | Out of universe | Cambridge Europe Developed Buyout | €1B+ EV sponsored LBO | >€500M (PB cites large-cap) | >€1B EV | n/a | €1B–€5B EV |
| Mega Cap | Out of universe | Captured by Cambridge Europe Developed Mega | €5B+ EV; 22% of EU buyouts in 2024 were €1B+ deals | "Megadeals" = €1B+ | >€5B EV | n/a | €5B+ EV |
| Tier | GF Data (US/Canada PE-sponsored) | Lincoln International (LPMI) | Capstone / Uplevered standard | KKR (Lincoln-cited credit) | Pantheon (composite) |
|---|---|---|---|---|---|
| LMM | $1M–$5M (very small); $3M–$10M (small) | <$10M EBITDA = highest covenant-default rate, deepest LMM | $2M–$15M EBITDA | <$10M EBITDA | <$15M EBITDA |
| Core MM | $5M–$10M and $10M–$25M EBITDA | $10M–$40M EBITDA range | $15M–$75M EBITDA | $10M–$40M = lower MM lending; $40–100M = upper MM | $25M–$75M EBITDA |
| UMM | $25M–$50M+ EBITDA (top of GF universe) | $40M–$100M EBITDA | $75M–$150M EBITDA | $40M–$100M EBITDA | $75M–$150M EBITDA |
| Large Cap | Out of GF universe | $100M+ EBITDA (out of LPMI universe) | $150M–$500M EBITDA | $200M+ EBITDA = syndicated loan territory | $150M–$500M EBITDA |
| Mega Cap | n/a | n/a | $500M+ EBITDA | $500M+ EBITDA | $500M+ EBITDA |
| Tier | Argos Index (eurozone) | Lincoln EU equivalent | Houlihan Lokey EU MidCapMonitor | AIC analog / practitioner |
|---|---|---|---|---|
| LMM | EBITDA ≥~€2M implied (€15M equity / 7-9x) | <€10M EBITDA | <€10M EBITDA | <€10M EBITDA |
| Core MM | ~€5M–€50M (€50M–€500M equity at 9-10x) | €10M–€40M EBITDA | €10M–€50M EBITDA | €10M–€50M EBITDA |
| UMM | ~€50M+ (top of €500M equity range) | €40M–€100M EBITDA | €50M–€100M EBITDA | €50M–€150M EBITDA |
| Large Cap | Out of universe | €100M+ EBITDA | €100M–€500M EBITDA | €150M–€500M EBITDA |
| Mega Cap | Out of universe | n/a | €500M+ EBITDA | €500M+ EBITDA |
| Tier | PitchBook | American Investment Council (AIC) | Capstone (revenue equiv) | NCMM standard | Bain (credit-defined MM) |
|---|---|---|---|---|---|
| LMM | $10M–$50M revenue | $11M–$100M revenue | $10M–$100M revenue | $10M–$100M revenue | n/a |
| Core MM | $50M–$500M revenue | $100M–$300M revenue | $100M–$500M revenue | $50M–$500M revenue | <$500M revenue (MM-credit bound) |
| UMM | $500M–$1B revenue | $300M–$500M revenue | $500M–$1B revenue | $500M–$1B revenue | n/a |
| Large Cap | $1B+ revenue | $500M+ (out of AIC MM) | >$1B | >$1B revenue | >$500M revenue |
| Mega Cap | Multi-billion | n/a | n/a | n/a | n/a |
| Tier | EU SME Definition (2003/361) | Invest Europe / Argos | PitchBook Europe | EU Small Mid-Cap (SMC) | Practitioner equivalent |
|---|---|---|---|---|---|
| Below LMM (SME) | Micro <€2M; Small <€10M; Medium <€50M turnover | Below mid-market (under €15M equity) | Below MM | Captured | <€50M revenue |
| LMM | Above SME (Medium up to €50M turnover) | Bottom of mid-market (€15–50M equity) | <€100M revenue | SMC being defined: under proposal <500 employees | €50M–€100M revenue |
| Core MM | Above SME | €50M–€300M revenue (Argos sample) | €100M–€500M revenue | Above SMC | €100M–€500M revenue |
| UMM | n/a | €300M–€1B revenue | €500M–€1B revenue | n/a | €500M–€1B revenue |
| Large Cap | n/a | >€1B revenue | >€1B revenue | n/a | >€1B revenue |
| Mega Cap | n/a | Multi-billion | Multi-billion | n/a | Multi-billion |
| Tier | Typical equity check | Deal value (transaction) | StepStone targeting | Cambridge Associates underlying band |
|---|---|---|---|---|
| LMM | $5M–$50M equity | $10M–$100M deal value | $15M–$50M check | <$250M EV (small cap) |
| Core MM | $50M–$200M equity | $100M–$500M | $50M–$200M | $250M–$1B EV |
| UMM | $200M–$500M equity | $500M–$1B | $200M+ | $1B–$2.5B EV |
| Large Cap | $500M–$2B equity | $1B–$5B | n/a | $2.5B–$10B EV |
| Mega Cap | $2B+ equity | $5B+ deal value | n/a | $10B+ EV |
StepStone (Wikipedia profile): targets equity checks $15M–$200M in firms with EV $150M–$2.5B — characteristic mid-/upper-mid range. Bain: $1B+ deals = 77% of US value in 2024; megadeals = $5B+ N. Am.
| Tier | Equity check | Deal value | Eurazeo Elevate / Capital | HarbourVest practitioner |
|---|---|---|---|---|
| LMM | €5M–€50M | €15M–€100M | Elevate equity tickets up to €150M | <€100M deal |
| Core MM | €50M–€150M | €100M–€500M | Capital upper midcap | €100M–€500M |
| UMM | €150M–€500M | €500M–€1B | Capital | €500M–€1B |
| Large Cap | €500M–€2B | €1B–€5B | n/a | €1B–€5B |
| Mega Cap | €2B+ | €5B+ | n/a | €5B+ (Baird: 22% of EU 2024 buyouts >€1B) |
The cleanest sources that segment narrowly are:
| Tier | Cambridge / StepStone implied bands | Growth-equity GP self-positioning | Practitioner synthesis |
|---|---|---|---|
| LMM Growth | $25M–$100M EV | Spectrum Equity, Silversmith ($25M–$200M EV) | $25M–$100M EV |
| Core MM Growth | $100M–$500M EV | TA Associates, Summit Partners ($100M–$1B EV typical) | $100M–$500M EV |
| UMM Growth | $500M–$2B EV | TA, Summit, General Atlantic, JMI Equity (entry $500M–$3B EV) | $500M–$2B EV |
| Large Cap Growth | $2B+ EV | General Atlantic, Insight (large-cap fund), Blackstone Growth, KKR Tech Growth, Vista Foundation | $2B–$10B EV |
| Mega Cap Growth | Out of narrow definition | Insight Partners, Vista flagship (hybrid buyout/growth) | Bleeds into mega-buyout |
| Tier | Practitioner synthesis (PipelineRoad, GE Interview Guide) | StepStone profile | Cambridge implied |
|---|---|---|---|
| LMM Growth | $10M–$50M revenue, growing 25%+ | $10M–$50M revenue, >20% growth | Bootstrap stage |
| Core MM Growth | $50M–$200M revenue | $50M–$200M revenue | Profitable core |
| UMM Growth | $200M–$500M revenue | $200M–$500M revenue | Pre-IPO scale |
| Large Cap Growth | $500M+ revenue, near-IPO scale | Out of narrow definition; verges into late-stage VC | Crossover range |
Most-cited operational profile (PipelineRoad): "$10–100M revenue, growing 15–40% annually, profitable or approaching profitability, founder-led, large addressable market."
EBITDA is structurally weak as a primary anchor for growth equity:
Practical EBITDA bands implied by GP self-disclosures:
Most LPs do not anchor growth equity tiers on EBITDA. They use revenue growth + profitability flag (yes/no) + EV.
| Tier | Practitioner / GrowthCap-cited check sizes |
|---|---|
| LMM Growth | $20M–$50M check |
| Core MM Growth | $50M–$200M check |
| UMM Growth | $200M–$500M check |
| Large Cap Growth | $500M–$2B check (Insight, GA, KKR Growth Tech) |
European growth equity data is even thinner than US data. The European market is materially smaller and less crisply segmented from VC.
| Tier | EV (€) | Revenue (€) | Source / Note |
|---|---|---|---|
| LMM Growth | €25M–€100M EV | €10M–€50M revenue | Verdane, Hg Mercury (Hg's lower-cap), Eurazeo Elevate up to €150M ticket |
| Core MM Growth | €100M–€500M EV | €50M–€300M revenue | TA Europe, Summit Europe, Hg Genesis |
| UMM Growth | €500M–€2B EV | €300M–€1B revenue | Hg Saturn, GA, KKR Tech Growth EU |
| Large Cap Growth | €2B+ EV | €1B+ revenue | Limited universe; mostly software (Hg Saturn, Vista, Permira) |
Data quality warning for Europe: Invest Europe groups growth/expansion into its Mid-Market Platform rather than separately. Cambridge Associates' "Ex US Growth Equity" benchmark has a small sample. Most European growth-equity deals can equally be described as small-cap buyouts using minority/structured-majority structures.
This is the critical comparison table to map the family office's current size-based framework to deal-level economics.
| Fund Size Bucket | Cambridge Associates US Buyout Matrix | Preqin (vintage 2005–2016) | Hamilton Lane | PitchBook | Underlying deal EV (typical) | Equity check (typical) |
|---|---|---|---|---|---|---|
| Small-Cap Buyout fund | <$1B (varies by vintage) | ≤$500M | "SMID" — varies by vintage | <$1B fund → LMM/MM deals | $25M–$500M EV | $5M–$100M check |
| Mid-Cap Buyout fund | $1B–$3.5B (vintage 2006–2015) | $501M–$1.5B | Embedded in SMID | $1B–$5B fund → core/upper MM | $250M–$2B EV | $50M–$300M check |
| Large-Cap Buyout fund | $3.5B–$10B (vintage 2006–2015) | $1.5B–$4.5B | "Mega/Large" — depends on vintage | $5B–$10B fund → UMM/large-cap | $1B–$5B EV | $200M–$1B check |
| Mega-Cap Buyout fund | >$10B (vintage 2006–2015); was >$3.5B for vintages 2000–2005 | >$4.5B | "Mega/Large" top end | >$10B fund → mega deals | $5B+ EV | $1B+ check |
| Current threshold | Industry standard alignment | Drift commentary |
|---|---|---|
| <$5bn = Middle Market | Cambridge: small + mid-cap (<$3.5B); Preqin: small + mid (<$4.5B); PitchBook: mid-market funds = $100M–$5B | Reasonably aligned with PitchBook; on the high side vs Cambridge; on the low side vs Preqin |
| $5–10bn = Large Cap | Cambridge: large-cap = $3.5B–$10B; Preqin: large = $1.5–4.5B | Reasonable for Cambridge; misaligned with Preqin (would be partly mega) |
| $10bn+ = Mega Cap | Exact match to Cambridge's published mega threshold for vintages 2006–2015 | Aligned |
Across the 18 sources reviewed, Enterprise Value (EV) at entry is the dominant primary anchor, used by PitchBook, Hamilton Lane (deal-level), Capstone Partners, AXA IM Alts, Pantheon, HarbourVest, Argos (via equity value, an EV proxy), Houlihan Lokey, Harris Williams, and most fund-of-funds. EBITDA is the dominant secondary anchor, used as the primary anchor by GF Data, Lincoln International, KKR (for credit), and as a critical filter on EV. Revenue is the dominant industry-association and regulatory anchor (AIC, NCMM, EU SME, Invest Europe member-survey methodology), but is rarely the primary anchor for sophisticated LP deal-level segmentation. Fund size remains the most-used proxy at the fund-commitment level (Cambridge, Preqin, Hamilton Lane fund-level analysis) but is universally recognized as a lagging proxy for deal economics.
The most sophisticated frameworks combine at least two of (EV, EBITDA, Revenue) plus qualifiers:
Notably, no sophisticated LP relies on EV alone or revenue alone. The dominant pattern is EV as primary anchor + EBITDA as secondary anchor + leverage and sector as qualifiers.
Because EBITDA and leverage are weak segmentation metrics for growth equity, sophisticated growth-focused LPs (StepStone, Cambridge, Callan) tend to use:
Without these qualifiers, any growth-equity dataset will be polluted by Series C/D crossover deals that have categorically different risk profiles.
| Tier | US (primary: EV; secondary: EBITDA) | Europe (primary: EV; secondary: EBITDA) |
|---|---|---|
| Lower MM (LMM) | EV $25M–$250M AND EBITDA $5M–$25M | EV €25M–€150M AND EBITDA €3M–€15M |
| Core MM | EV $250M–$1B AND EBITDA $25M–$75M | EV €150M–€500M AND EBITDA €15M–€50M |
| Upper MM (UMM) | EV $1B–$2.5B AND EBITDA $75M–$200M | EV €500M–€1.5B AND EBITDA €50M–€150M |
| Large Cap | EV $2.5B–$10B AND EBITDA $200M–$750M | EV €1.5B–€7.5B AND EBITDA €150M–€500M |
| Mega Cap | EV >$10B AND EBITDA >$750M | EV >€7.5B AND EBITDA >€500M |
Anchored on Hamilton Lane's $1–3B TEV middle-market definition (more current than PitchBook's $25M–$1B), Cambridge's $10B mega threshold, and GF Data / Lincoln EBITDA bands. European bands scaled at ~60–80% of US bands, consistent with Argos, Invest Europe, AXA IM Alts, and HarbourVest practice.
| Tier | US (primary: Revenue; profitability filter required) | Europe |
|---|---|---|
| LMM Growth | Revenue $10M–$50M AND growth ≥25% AND ≤24 months to profitability AND ≤1.0x leverage AND limited prior institutional capital | Revenue €5M–€30M with same filters |
| Core MM Growth | Revenue $50M–$200M with same filters | Revenue €30M–€150M with same filters |
| UMM Growth | Revenue $200M–$500M with same filters | Revenue €150M–€400M with same filters |
| Large Cap Growth | Revenue $500M–$2B with same filters (rare in Europe) | Revenue €400M–€1.5B with same filters |
Critical exclusions: (i) reject any company more than 24 months from profitability per management's plan; (ii) reject any company whose entry round is a Series C/D/E priced as a pre-profit valuation step-up in a continuing dilution sequence; (iii) reject any deal where the GP markets it as "growth-stage VC," "crossover," or "late-stage VC" (this filter alone removes Tiger Global, Coatue, Dragoneer, Iconiq, and parts of Insight Partners' deal flow).
| Strategy | Small | Mid | Large | Mega |
|---|---|---|---|---|
| US Buyout fund | <$1B | $1B–$3.5B | $3.5B–$10B | >$10B |
| EU Buyout fund | <€750M | €750M–€2.5B | €2.5B–€7.5B | >€7.5B |
| US Growth Equity fund | <$500M | $500M–$2B | $2B–$5B | >$5B (rare in narrow growth) |
| EU Growth Equity fund | <€500M | €500M–€1.5B | €1.5B–€3.5B | >€3.5B |
This framework retains continuity with Cambridge Associates, Preqin, and Hamilton Lane fund-size matrices while making the deal-level multi-metric rules above the primary segmentation, and fund-size the secondary cross-reference.
A multi-metric rule framework — EV as primary anchor, EBITDA as secondary, with explicit profitability and leverage filters for growth equity — provides materially better resolution than fund size alone for a $9bn family office's purposes. It will:
The framework should be reviewed every 2–3 years to adjust for multiple-cycle drift, mirroring Cambridge Associates' practice of resetting its fund-capitalization matrix by vintage.